Pericarditis
BASICS
- Definition: Inflammation of the pericardium, with or without pericardial effusion.
- Myopericarditis/perimyocarditis: Myocardial and pericardial involvement.
EPIDEMIOLOGY
- Incidence: ~27.7/100,000 per year
- Recurrence: ~30% after first episode within 18 months
ETIOLOGY & PATHOPHYSIOLOGY
- Idiopathic (85β90%): Mostly viral, immune-related
- Common viruses: Coxsackievirus, echovirus, adenovirus, EBV, CMV, hepatitis, influenza, HIV, mumps, varicella, SARS-CoV-2, parvovirus B19
- Bacterial: M. tuberculosis, S. aureus, S. pneumoniae, anaerobes (rare in developed countries)
- Fungal/Parasite: In immunocompromised
- Noninfectious (15β20%):
- Acute MI (post-infarction), Dressler syndrome, aortic dissection, uremia, malignancy, radiation, trauma, post-procedural (e.g., post-cardiac surgery), autoimmune/connective tissue disease (SLE, RA, scleroderma, sarcoidosis, IBD, Wegener)
- Medications: dantrolene, doxorubicin, hydralazine, isoniazid, mesalamine, methysergide, penicillin, phenytoin, procainamide, rifampin
- Vaccination (smallpox, influenza, SARS-CoV-2 mRNA)
- Genetics: Familial Mediterranean fever, TRAPSβlinked to recurrent pericarditis
RISK FACTORS
- Thoracic surgery, CKD, pneumonia, autoimmune disease, radiation (lung/breast CA), chronic infection
DIAGNOSIS
- Criteria (need β₯2 of 4):
- Pleuritic chest pain
- Pericardial friction rub
- New/increasing pericardial effusion (imaging)
- ECG: widespread ST-segment elevation (diffuse), PR depression
- Classification:
- Incessant: symptoms >4β6 weeks but <3 months
- Recurrent: symptoms recur after β₯4β6 weeks symptom-free
- Chronic: >3 months
Myopericarditis:
- Definite pericarditis PLUS:
- Symptoms (dyspnea, chest pain, palpitations) and new ECG changes or LV dysfunction on imaging
- Elevated cardiac enzymes OR abnormal MRI/gallium scan
HISTORY
- Viral prodrome (fever, malaise, myalgias, recent URI)
- Acute, sharp, pleuritic chest pain (radiates to trapezius; relieved by leaning forward, worse lying down)
- Shortness of breath
PHYSICAL EXAM
- Pericardial friction rub: coarse, high-pitched (left lower sternal border, leaning forward)
- May be transient, variable phases
- S3 may suggest myopericarditis
DIFFERENTIAL
- MI/ACS, PE, aortic dissection, GERD, pneumonia
DIAGNOSTIC TESTS
- Labs:
- Leukocytosis
- β ESR/CRP/LDH
- β Troponin/CK (esp. myopericarditis, but not prognostic)
- ECG:
- Diffuse ST-elevation (concave), PR depression, low voltage or electrical alternans (large effusion/tamponade)
- Echo:
- Evaluate for pericardial effusion, tamponade, or myocardial disease
- CXR:
- Rule out other causes, cardiomegaly if large effusion
- CT/MRI:
- Evaluate pericardium, complications, pre-op planning
- Other:
- TSH, TB test, ANA, RF, HIV serology if indicated
- Pericardiocentesis: For tamponade, suspected purulent/TB/neoplastic, effusions >20mm on echo
TREATMENT
General Measures
- Treat underlying cause
- Restrict physical activity (especially recurrences)
Medications
- First Line:
- NSAIDs: Mainstay for acute pericarditis (Ibuprofen 600 mg TID, Aspirin 1000 mg TID, Indomethacin 50 mg TID; 7β10 days, then taper)
- Aspirin preferred post-MI
- Indomethacin avoid in elderly/CAD
- GI protection with PPI
- Taper only when asymptomatic + normalized CRP/ESR (monitor 1β2 weeks)
- Colchicine:
- 0.5β0.6 mg BID (up to 3 months; up to 6 months if recurrent)
- Use with NSAIDs (not alone)
- Only agent proven to prevent recurrence (reduces by ~50%)
- Adjust for renal/hepatic dysfunction
- Monitor CBC, LFTs, CK, creatinine at baseline/1 month; CRP weekly
- Pregnancy:
- <20 wks: Aspirin preferred; NSAIDs/prednisone allowed
-
20 wks: Prednisone only; avoid NSAIDs/aspirin/colchicine
-
Second Line:
- Steroids: Only if NSAID/colchicine contraindicated or in CTD/TB pericarditis; avoid in uncomplicated/idiopathic acute pericarditis.
- Low dose (0.2β0.5 mg/kg/day) until symptom/CRP normalization, then taper
- Add calcium/vitamin D; consider bisphosphonate in high-risk
- IL-1 antagonists:
- Anakinra (2 mg/kg SC daily, up to 100 mg; 2β6 months)
- Rilonacept (320 mg SC, then 160 mg weekly x12 weeks)
- Use for refractory/recurrent cases
- Monitor for injection site, LFTs, infections
SURGERY/PROCEDURES
- Pericardiocentesis: Tamponade, purulent/TB/neoplastic effusions, refractory large symptomatic effusion
- Pericardial window: Recurrent tamponade/effusion unresponsive to other tx
- Pericardiectomy: Chronic constrictive pericarditis (NYHA III/IV) only if severe, high-mortality procedure
ADMISSION & INPATIENT CONSIDERATIONS
- Admit for:
- Major comorbidities
- Refractory cases
- Uremic/dialysis pericarditis
- Suspected/actual tamponade
-
Immunosuppression, trauma, anticoagulation, myopericarditis, fever >38Β°C, large effusion, subacute onset, no NSAID/aspirin response
-
IV fluids: Hypotension/tamponade
ONGOING CARE
- Follow-up: 1 week (response, CBC, CRP), then as needed based on risk/echo
- Myopericarditis: Lower dose anti-inflammatories, 4β6 weeks exercise restriction (athletes: β₯3 months)
- Echo: At 1, 6, 12 months (esp. LV dysfunction)
PROGNOSIS
- Generally good if underlying cause treated; most cases benign/self-limited
- Poor in purulent/TB pericarditis
COMPLICATIONS
- Recurrence: 15β30% (often idiopathic, viral, autoimmune; usually within 1 week but can occur years later)
- Cardiac tamponade: rare, more common in neoplastic, purulent, TB pericarditis
- Effusive-constrictive pericarditis: 8β24% of surgical/pericardiocentesis cases (diagnosis: right atrial pressure fails to drop post-pericardiocentesis)
- Constrictive pericarditis: rare but severe; requires pericardiectomy
- Arrhythmias: Atrial fibrillation/flutter
ICD-10 CODES
- I31.9 Disease of pericardium, unspecified
- I30.9 Acute pericarditis, unspecified
- I30.1 Infective pericarditis
CLINICAL PEARLS
- NSAIDs + colchicine = first-line therapy; colchicine reduces recurrence by ~50%
- Therapy targets symptom relief, recurrence prevention
- Monitor for high-risk features (effusion, tamponade, recurrence)